RIGEL PHARMACEUTICALS INC Income Statement
RIGL / Health Care|11 years of annual SEC 10-K data (FY2015-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 11 fiscal years. All figures from audited SEC 10-K filings.
RIGEL PHARMACEUTICALS INC reported $294M in revenue and $367M in net income for FY2025. Revenue has grown at a 34.5% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $294.3M | $179.3M | $116.9M | $120.2M | $149.2M | $108.6M | $59.3M | $20.4M | $4.5M | $20.4M | - |
| Cost of Revenue | $19.6M | $18.6M | $7.1M | $1.7M | $1.1M | $895.0K | $906.0K | $287.0K | - | - | - |
| Gross Profit | - | - | - | - | - | - | $7.9M | $1.8M | - | - | - |
| SG&A Expense | $115.9M | $113.1M | $105.7M | $112.5M | $91.9M | $76.6M | $74.6M | $20.9M | $37.8M | $20.9M | $17.8M |
| R&D Expense | $33.3M | $23.4M | $24.5M | $60.3M | $65.2M | $60.1M | $52.9M | $63.4M | $46.3M | $63.4M | $62.8M |
| Operating Income | $125.5M | $24.2M | -$20.5M | -$55.5M | -$12.5M | -$29.0M | -$69.1M | -$69.7M | -$79.6M | -$69.7M | -$51.7M |
| Interest Expense | - | $7.9M | $6.9M | $3.7M | $4.9M | $1.4M | $335.0K | - | - | - | - |
| Income Tax | -$245.2M | $881.0K | $0 | - | $605.0K | - | - | $0 | $0 | $0 | $0 |
| Net Income | $367.0M | $17.5M | -$25.1M | -$58.6M | -$17.9M | -$29.7M | -$66.9M | -$69.2M | -$78.0M | -$69.2M | -$51.5M |
| EPS (Basic) | -$1.44 | -$3.44 | -$0.11 | -$0.18 | -$0.40 | - | - | - | - | - | - |
| EPS (Diluted) | -$1.44 | -$3.44 | -$0.11 | -$0.18 | -$0.40 | -$0.44 | -$0.62 | -$0.73 | - | - | - |
| Shares Outstanding | 17.7M | 17.5M | 173.4M | 171.6M | 169.3M | 168.0M | 167.2M | 146.8M | 126.3M | 94.4M | 88.4M |
| Gross Margin | - | - | - | - | - | - | 13.4% | 8.6% | - | - | - |
| Operating Margin | 42.6% | 13.5% | -17.5% | -46.2% | -8.4% | -26.7% | -116.5% | -342.1% | - | - | - |
| Profit Margin | 124.7% | 9.8% | -21.5% | -48.7% | -12.0% | -27.4% | -112.8% | -339.6% | - | - | - |